Is China’s work ethic a ‘wake-up call’?; The megamerger that wasn’t; and more
Welcome back to the Weekly! The Endpoints News team gathered a group of industry experts in Cambridge, MA this week to debate the future of China biotech. During one of the panels, Pfizer’s Andrew Baum ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
